Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group - Colwell, CW, Jr; Spiro, TE; Trowbridge, AA (J Bone Joint Surg Am, 1994)